Provider Recent FDA-Approved Medical Drugs or Medical Drug Indications Evaluation Process List Read More
Provider QP54-25 “Serious Illness Conversations: Improving Patient Care at End of Life” Training Available July/August 2025 Read More Program effective Date: Jun 25, 2025
Provider QP53-25 Update for New-to-Market Medical Drugs: nipocalimab-aahu Read More Program effective Date: Jun 25, 2025